MBZUAI researchers developed Human-in-the-Loop for Prognosis (HuLP), a new AI system designed to help physicians assess cancer progression by providing information about its predictions and allowing user intervention. The system aims to foster collaboration between physicians and AI, rather than replacing doctors. It was presented at the 27th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). Why it matters: This research highlights the potential of AI to augment physician expertise in critical areas like cancer prognosis, improving patient care and treatment decisions.
Researchers at MBZUAI have developed a new machine learning method called survival rank-n-contrast (SurvRNC) to improve survival models for cancer prognoses. The method is designed to predict survival times for head and neck cancer patients using multimodal data while accounting for censored data (missing values). Numan Saeed presented the team’s work at the 27th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). Why it matters: Accurate prognoses can significantly improve patient outcomes, and this research contributes to advancements in machine learning techniques for handling complex and incomplete medical data.
This article discusses the use of artificial intelligence in precision oncology, particularly in understanding individual tumor mechanisms and aiding clinical decision-making. Dr. Xinghua Lu, with extensive experience in medicine and biomedical informatics, will present research on individualized Bayesian causal inference methods for investigating oncogenic mechanisms. These methods aim to provide clinical decision support at the cellular, tumor, and patient levels. Why it matters: AI-driven precision oncology can enable more personalized and effective cancer treatments, improving patient outcomes in the region and globally.
A senior lecturer at the University of New South Wales discussed the use of AI to improve early prognosis and personalized treatment plans for neurodegenerative diseases, cardiovascular imaging and multiomics. The lecture highlighted the potential of AI algorithms to detect subtle changes at early stages through advanced multiomics techniques and medical imaging analysis. The speaker has expertise in analyzing medical images and has collaborated with medical professionals to develop AI tools for diagnosis of cancer, neurodegenerative disease, and heart disease. Why it matters: AI-driven prognosis and treatment planning promises earlier intervention and improved outcomes for challenging diseases in the region.
MBZUAI's first Ph.D. graduate, Numan Saeed, developed deep learning models to diagnose head and neck cancers using PET and CT scan imagery. His research focused on improving early detection and accurate localization of tumors, aiming to enhance diagnosis and prognosis. Early diagnosis can reduce mortality rates by up to 70%. Why it matters: This research showcases the potential of AI in healthcare to improve cancer diagnosis and treatment, addressing a critical need in resource-constrained healthcare systems.